Literature DB >> 7132735

The conversion of phenylalanine to tyrosine in man. Direct measurement by continuous intravenous tracer infusions of L-[ring-2H5]phenylalanine and L-[1-13C] tyrosine in the postabsorptive state.

J T Clarke, D M Bier.   

Abstract

Steady state phenylalanine and tyrosine turnover and the rate of conversion of phenylalanine of tyrosine in vivo were determined in 6 healthy postabsorptive adult volunteers. Continuous infusions of tracer amounts of L-[ring-2H5]phenylalanine were determined intravenously for 13-14 hr. After 9-10 hr, a priming dose followed by a continuous infusion of L-[1-13C]tyrosine was added and maintained, along with the [2H5]phenylalanine infusion, for 4 hr. Venous plasma samples were obtained before the initiation of each infusion and every 30 min during the course of the combined [2H5]phenylalanine and [13C]tyrosine infusion for determination of isotopic enrichments of [2H5]phenylalanine, [13C]tyrosine, and [2H4]tyrosine by gas chromatograph-mass spectrometric analysis of the N-trifluoroacetyl-, methyl ester derivatives of the amino acids. Calculated from the observed enrichments, free phenylalanine and tyrosine turnover rates were 36.1 +/- 5.1 mumole . kg-1 . h-1 and 39.8 +/- 3.5 mumole . kg-1 . h-1, respectively. Phenylalanine was converted to tyrosine at the rate of 5.83 +/- 0.59 mumole . kg-1 . h-1, accounting for approximately 16% of either the phenylalanine or the tyrosine flux. The results indicate that the normal basal steady state phenylalanine hydroxylase activity in vivo in man is lower than that obtained from phenylalanine loading studies. This supports the existence of some type of substance activation of the enzyme as reflected in the previously reported exponential relationship between phenylalanine concentration and phenylalanine hydroxylase activity in vitro. The use of continuous simultaneous infusions of tracer amounts of stable isotope-labeled phenylalanine and tyrosine provides a direct means for studying physiological regulation of phenylalanine hydroxylase activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7132735     DOI: 10.1016/0026-0495(82)90142-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  25 in total

1.  Anabolic signaling and protein deposition are enhanced by intermittent compared with continuous feeding in skeletal muscle of neonates.

Authors:  Samer W El-Kadi; Agus Suryawan; Maria C Gazzaneo; Neeraj Srivastava; Renán A Orellana; Hanh V Nguyen; Gerald E Lobley; Teresa A Davis
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-03       Impact factor: 4.310

2.  Phenylalanine kinetics in human adipose tissue.

Authors:  S W Coppack; M Persson; J M Miles
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Techniques for studying hepatic metabolism in vivo.

Authors:  J V Leonard; G N Thompson
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 4.  Pathophysiology of sympathoadrenal system.

Authors:  R Giorgino
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

5.  Oral aspartame and plasma phenylalanine: pharmacokinetic difference between rodents and man, and relevance to CNS effects of phenylalanine. Short note.

Authors:  J D Fernstrom
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

6.  Whole body nitric oxide synthesis in healthy men determined from [15N] arginine-to-[15N]citrulline labeling.

Authors:  L Castillo; L Beaumier; A M Ajami; V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

7.  A four-compartment compartmental model to assess net whole body protein breakdown using a pulse of phenylalanine and tyrosine stable isotopes in humans.

Authors:  Alvise Mason; Mariëlle P K J Engelen; Ivan Ivanov; Gianna M Toffolo; Nicolaas E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-03-07       Impact factor: 4.310

8.  Significant phenylalanine hydroxylation in vivo in patients with classical phenylketonuria.

Authors:  G N Thompson; D Halliday
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

9.  The contribution of phenylalanine to tyrosine metabolism in vivo. Studies in the post-absorptive and phenylalanine-loaded rat.

Authors:  L L Moldawer; I Kawamura; B R Bistrian; G L Blackburn
Journal:  Biochem J       Date:  1983-03-15       Impact factor: 3.857

10.  Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets.

Authors:  L Castillo; T E Chapman; M Sanchez; Y M Yu; J F Burke; A M Ajami; J Vogt; V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.